Sign up to The Irish Times Archive (1859 - 2008)My Account »

Northern Ireland pharmaceutical firm Galen has added to its presence in the dermatology market after signing agreements relating to two drugs for the treatment of psoriasis.

Galen, which specialises in women's health, urology and skincare, has entered into a co-promotion agreement with Bristol-Myers Squibb for Dovonex in the US.